Skip to main content
. 2020 May 27;6(22):eaba3167. doi: 10.1126/sciadv.aba3167

Fig. 5. Antifibrosis mechanism with dual drugs synergy.

Fig. 5

(A) Expression of the vimentin in vitro. (B) The ROS level in vitro. (C) The changes of mitochondrial membrane potential. (D) Invasion assay. (E) Fibronectin expression. (F) H&E, Masson, and IHC staining. (G) The level of hydroxyproline. (H) The α-SMA and β-actin by Western blotting. The mRNA expression of Acta2 (I) and Ctgf (J) by qPCR (n = 3). Contents of GSH (K), MDA (L), and SOD (M) (n = 5). Statistical significance was calculated via one-way ANOVA.